Skip to content
Screener

Mesa Laboratories MLAB Q4 2025 Annual earnings

Reported May 28, 2025 · Before market open

Revenue$62.1MBeat by $235.0K
EPS$2.23Miss by $0.52
Revenue estimate$61.9M
EPS estimate$2.75

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$61.6M
EPS estimate$1.59

Financials

Q4 2025

Income statement

See full
Revenue$62.1M+5.5%
Net income-$7.1M+97.2%

Balance sheet

See full
Cash & equivalents$27.3M-3.2%
Total debt$167.7M+5,517%
Total equity$159.8M+9.9%
Total assets$433.3M-3.0%

Cash flow

See full
Operating cash flow$12.7M-1.7%
CapEx$757.0K+41.5%
Free cash flow$11.9M-3.6%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$644.75M+9.0%
Enterprise value$785.15M+38.6%
P/S2.7×-0.1×

Profitability

See full
Net margin-0.8%-0.4pp
FCF margin17.7%-1.6pp

Returns & leverage

See full
Return on equity-1.3%-0.6pp
Debt / equity1×+1.0×
Current ratio0.6×-1.8×

Segments

By geography

See full
US$31.2M+14.7%
Other$25.9M+2.1%
CN$5.0M-20.6%

By segment

See full
Biopharmaceutical Development$12.6M+3.5%
Clinical Genomics$11.5M+3.5%

FAQ

When did Mesa Laboratories report Q4 2025 earnings?
Mesa Laboratories (MLAB) reported Q4 2025 earnings on May 28, 2025 before market open.
What were Mesa Laboratories's Q4 2025 revenue and EPS?
Mesa Laboratories reported revenue of $62.1M and eps of $2.23 for Q4 2025.
Did Mesa Laboratories beat estimates in Q4 2025?
Revenue beat the consensus estimate of $61.9M by $235.0K. EPS missed the consensus estimate of $2.75 by $0.52.
How did Mesa Laboratories's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.5% from $58.9M a year earlier and eps declined 19.5% from $2.77.
Where can I find Mesa Laboratories's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-018585) and the 10-K periodic report (0001437749-25-018586) directly on SEC EDGAR. The filing index links above go to sec.gov.